91 related articles for article (PubMed ID: 7994279)
1. High-titre interferon-alpha antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Prümmer O; Bunjes D; Wiesneth M; Arnold R; Porzsolt F; Heimpel H
Bone Marrow Transplant; 1994 Sep; 14(3):483-6. PubMed ID: 7994279
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to interferon-alpha: a novel type of autoantibody occurring after allogeneic bone marrow transplantation.
Prümmer O; Bunjes D; Wiesneth M; Hertenstein B; Arnold R; Porzsolt F; Heimpel H
Bone Marrow Transplant; 1996 Apr; 17(4):617-23. PubMed ID: 8722365
[TBL] [Abstract][Full Text] [Related]
3. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
[TBL] [Abstract][Full Text] [Related]
4. Multicenter prospective study of interferon-alpha and conventional chemotherapy versus bone marrow transplantation for newly diagnosed patients with chronic myelogenous leukemia. Kouseisho Leukemia Study Group.
Ohnishi K; Minami S; Ueda T; Nishimura M; Tsubaki K; Takemoto Y; Takeshita A; Sao H; Kageyama S; Ueda R; Ohno R
Int J Hematol; 2000 Aug; 72(2):229-36. PubMed ID: 11039674
[TBL] [Abstract][Full Text] [Related]
5. Graft-versus-host disease following interferon therapy for relapsed chronic myeloid leukaemia post-allogeneic bone marrow transplantation.
Browett PJ; Nelson J; Tiwari S; Van de Water NS; May S; Palmer SJ
Bone Marrow Transplant; 1994 Oct; 14(4):641-4. PubMed ID: 7858542
[TBL] [Abstract][Full Text] [Related]
6. Intracellular cytokine analysis of interferon-gamma in T cells of patients with chronic myeloid leukemia.
Aswald JM; Lipton JH; Messner HA
Cytokines Cell Mol Ther; 2002 Dec; 7(2):75-82. PubMed ID: 12607798
[TBL] [Abstract][Full Text] [Related]
7. Role of pretransplant interferon-alpha(IFN) treatment in the outcome of stem cell transplantation (SCT) from related donors in chronic myelogenous leukemia (CML): results from three Turkish transplant centers.
Beksac M; Celebi H; Sargín D; Yalcin A; Topcuoglu P; Kalayoglu-Besisik S; Beyan C; Arslan O; Ozcan M; Gurman G; Ilhan O; Akan H
Bone Marrow Transplant; 2003 May; 31(10):897-904. PubMed ID: 12748666
[TBL] [Abstract][Full Text] [Related]
8. Alpha-interferon with very-low-dose donor lymphocyte infusion for hematologic or cytogenetic relapse of chronic myeloid leukemia induces rapid and durable complete remissions and is associated with acceptable graft-versus-host disease.
Posthuma EF; Marijt EW; Barge RM; van Soest RA; Baas IO; Starrenburg CW; van Zelderen-Bhola SL; Fibbe WE; Smit WM; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 2004 Mar; 10(3):204-12. PubMed ID: 14993886
[TBL] [Abstract][Full Text] [Related]
9. Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignancies.
Toren A; Barak V; Novick D; Nagler A
Cytokines Cell Mol Ther; 1997 Sep; 3(3):153-8. PubMed ID: 9426973
[TBL] [Abstract][Full Text] [Related]
10. Interferon-alpha and interleukin-2 as treatment for leukemia relapse after allogeneic bone marrow transplantation.
Giralt S; O'Brien S; Talpaz M; Van Besien K; Chan KW; Rondón G; Andersson B; Mehra R; Khouri I; Estey E
Cytokines Mol Ther; 1995 Jun; 1(2):115-22. PubMed ID: 9384668
[TBL] [Abstract][Full Text] [Related]
11. Phimosis as a manifestation of chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Kami M; Kanda Y; Sasaki M; Takeda N; Tanaka Y; Saito T; Ogawa S; Honda H; Chiba S; Mitani K; Hirai H; Yazaki Y
Bone Marrow Transplant; 1998 Apr; 21(7):721-3. PubMed ID: 9578313
[TBL] [Abstract][Full Text] [Related]
12. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
[TBL] [Abstract][Full Text] [Related]
13. Anti-mitosin antibodies in a patient with chronic graft-versus-host disease after allogeneic bone marrow transplantation.
Muro Y; Kamimoto T; Hagiwara M
Bone Marrow Transplant; 1997 May; 19(9):951-3. PubMed ID: 9156273
[TBL] [Abstract][Full Text] [Related]
14. Interferon alpha for chronic myeloid leukemia relapsing after allogeneic bone marrow transplantation.
Steegmann JL; Casado LF; Tomás JF; Sanz-Rodríguez C; Granados E; de la Cámara R; Alegre A; Vázquez L; Ferro MT; Figuera A; Arranz R; Fernández-Rañada JM
Bone Marrow Transplant; 1999 Mar; 23(5):483-8. PubMed ID: 10100563
[TBL] [Abstract][Full Text] [Related]
15. [Effect of interferon-alpha on the prognosis of bone marrow transplantation in chronic myeloid leukemia].
Xu L; Guo N; Huang X
Zhonghua Xue Ye Xue Za Zhi; 2001 Nov; 22(11):589-91. PubMed ID: 11855148
[TBL] [Abstract][Full Text] [Related]
16. [Leukocyte transfusion as therapy of recurrent CML after allogenic bone marrow transplantation].
Wiesneth M; Hertenstein B; Bunjes D; Novotny J; Stefanic M; Heinze B; Schreiner T; Kubanek B; Heimpel H; Arnold R
Beitr Infusionsther Transfusionsmed; 1994; 32():276-80. PubMed ID: 9480108
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic cell therapy for relapsed leukemia after bone marrow transplantation with donor peripheral blood lymphocytes.
Slavin S; Naparstek E; Nagler A; Ackerstein A; Kapelushnik J; Or R
Exp Hematol; 1995 Dec; 23(14):1553-62. PubMed ID: 8542946
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment with donor leukocyte transfusion followed by interferon-alpha in a patient with relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation].
Maeda A; Yamamoto K; Kotone Y; Yamashita K; Yoshinaga N; Hirata H; Asagoe K; Nohgawa M; Takahashi A; Ohno H; Tashima M; Sasada M
Rinsho Ketsueki; 1998 Jun; 39(6):442-6. PubMed ID: 9695673
[TBL] [Abstract][Full Text] [Related]
19. A possible association between the presence of interleukin-4-secreting cells and a reduction in the risk of acute graft-versus-host disease.
Takabayashi M; Kanamori H; Takasaki H; Yamaji S; Koharazawa H; Taguchi J; Tomita N; Fujimaki K; Fujisawa S; Maruta A; Ishigatsubo Y
Exp Hematol; 2005 Feb; 33(2):251-7. PubMed ID: 15676220
[TBL] [Abstract][Full Text] [Related]
20. Role of splenic irradiation in patients with chronic myeloid leukemia undergoing allogeneic bone marrow transplantation.
Jabro G; Koc Y; Boyle T; Schenkein DP; Ravalese J; Wazer D; Miller KB
Biol Blood Marrow Transplant; 1999; 5(3):173-9. PubMed ID: 10392963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
